Quadrature Capital »

Candel Therapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $103k 21k 4.90

More positions owned by Quadrature Capital

Asml Hldg Nv N Y Registry Shs (ASML)
UnitedHealth (UNH)
Spdr Gold Tr Gold Shs (GLD)
Sap Se Spon Adr (SAP)
Micron Technology (MU)
Sandisk Corp (SNDK)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Circle Internet Group Com Cl A (CRCL)
Crowdstrike Hldgs Cl A (CRWD)
Intel Corporation (INTC)
Toronto Dominion Bk Ont Com New (TD)
Select Sector Spdr Tr State Street Ene (XLE)

View all positions for Quadrature Capital

Top funds holding Candel Therapeutics

FMR
Rtw Investments
Acorn Capital Advisors
BlackRock
Saturn V Capital Management
Portolan Capital Management
Vanguard Capital Management
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Heights Capital Management
Susquehanna International
Sands Capital Ventures

View all funds holding Candel Therapeutics